FDA Backs Gene Therapy for Fatal Neurodegenerative Childhood Disease – labiotech (press release) (blog)
labiotech (press release) (blog) |
FDA Backs Gene Therapy for Fatal Neurodegenerative Childhood Disease
labiotech (press release) (blog) Orchard Therapeutics has received a fourth Rare Pediatric Disease Designation from the FDA for its gene therapy candidate for metachromatic leukodystrophy. Orchard Therapeutics, based in London, has received a Rare Pediatric Disease Designation form … Morning brief: Herzuma launched in Europe, rare disease status for Orchard candidate and more Orchard Therapeutics Receives Rare Pediatric Disease Designation for MLD Therapy Orchard Therapeutics' OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of … |
